Pre-exposure prophylaxis, or PrEP, is the use of an anti-HIV medication by HIV negative individuals to prevent future acquisition of HIV. Currently, only one medication, Truvada, has been approved to use as PrEP by the FDA. When taken consistently on a daily basis, PrEP (in the form of Truvada) has been shown to reduce the risk of HIV infection by up to 92%.
AIDS United supports efforts to expand access to all appropriate HIV-prevention tools. We believe PrEP is a critically important prevention tool for many people faced with substantial risk of infection. AIDS United will advocate for education campaigns that share information about PrEP and how to access it. Additionally, AIDS United will advocate for federal funding streams that make PrEP accessible and affordable for high-risk populations.
VISA, Mastercard & AMEX accepted.
Help us make the promise of an AIDS-free generation a reality.
News and Updates
March 29, 2017, Washington D.C. – AIDSWatch, the largest constituent-based ...
Latest Blog Post
been hard to keep up with all the developments ...